Category US FDA

US FDA Announces Proposed Rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU)

The FDA is announcing the availability of the proposed rule Nonprescription Drug Product with an Additional Condition for Nonprescription Use (Docket No. FDA-2021-N-0862). The proposed rule is available for public comment for 120 days. Comments should be submitted to docket FDA-2021-N-0862 on Regulations.gov. …

Read More